Lidocaine + Ketamine for Postoperative Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if using lidocaine and ketamine (an anesthetic) during and after surgery can reduce opioid use and lower pain levels for those recovering from abdominal surgery. Participants will receive one of the following: lidocaine and ketamine, lidocaine and a placebo, ketamine and a placebo, or a placebo only. The goal is to find a safer and more effective method for managing post-surgical pain. This trial suits adults planning elective abdominal surgery under general anesthesia for at least two hours. As a Phase 3 trial, it represents the final step before FDA approval, offering participants the opportunity to contribute to a potentially groundbreaking pain management solution.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use gabapentin, magnesium, or nitrous oxide around the time of surgery. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
In past studies, both lidocaine and ketamine have shown promise in managing post-surgical pain. Research shows that lidocaine can reduce pain and lessen the need for opioids after an operation. Ketamine, when used in low doses, has also effectively managed pain without causing additional side effects.
When used together, lidocaine and ketamine have worked well. One study found that using both can improve pain relief during and after surgery. Importantly, this combination did not lead to more side effects.
However, while lidocaine is generally safe, it can be dangerous if not used correctly. Proper administration is crucial. Overall, evidence suggests that the combination of lidocaine and ketamine is well-tolerated and effective for managing pain.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they explore the combination of lidocaine and ketamine for managing postoperative pain. Unlike traditional pain relief methods, which often rely on opioids or NSAIDs, this approach leverages ketamine's unique ability to block certain pathways in the brain that process pain, potentially offering faster and more effective pain relief. Lidocaine, known for its local anesthetic properties, complements ketamine by stabilizing nerve activity and reducing inflammation. Together, they could provide a powerful alternative that minimizes the risk of side effects associated with long-term opioid use, making them a promising option for patients recovering from surgery.
What evidence suggests that this trial's treatments could be effective for reducing postoperative pain?
Research has shown that both lidocaine and ketamine can reduce pain and the need for opioids after surgery. In this trial, participants may receive either lidocaine and ketamine together, lidocaine with a placebo, or ketamine with a placebo. Studies indicate that adding ketamine to lidocaine can decrease the amount of pain medication needed during and after surgery. This combination also relieves pain more effectively than using either one alone. Ketamine alone has been shown to lessen pain and reduce opioid use. It also aids recovery by lowering the risk of nausea and vomiting. Together, these treatments offer promising benefits for managing pain after surgery.678910
Who Is on the Research Team?
Steven Minear, MD
Principal Investigator
Cleveland Clinic Florida
Are You a Good Fit for This Trial?
Adults aged 18-80 undergoing elective inpatient abdominal surgery with general anesthesia lasting over 2 hours can join. Excluded are pregnant or breastfeeding individuals, those needing post-op ventilation, using certain drugs like gabapentin, obese patients (BMI ≥35), people with severe heart failure or communication issues, and those allergic to the study meds.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive perioperative infusions of lidocaine and/or ketamine during abdominal surgery
Postoperative Monitoring
Participants are monitored for opioid consumption, pain scores, and other outcomes for 48 hours post-surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ketamine
- Lidocaine
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor